{"pmid":32382684,"pmcid":"PMC7202807","title":"The mutual effects of COVID-19 and obesity.","text":["The mutual effects of COVID-19 and obesity.","*The rate of obesity was increased during this era of the COVID-19 epidemic.*Obesity is dangerous in COVID-19 patients.","Obes Med","Abbas, Ahmed M","Fathy, Safaa K","Fawzy, Andro T","Salem, Amera S","Shawky, Mario S","32382684"],"abstract":["*The rate of obesity was increased during this era of the COVID-19 epidemic.*Obesity is dangerous in COVID-19 patients."],"journal":"Obes Med","authors":["Abbas, Ahmed M","Fathy, Safaa K","Fawzy, Andro T","Salem, Amera S","Shawky, Mario S"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382684","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.obmed.2020.100250","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666267276708413440,"score":9.490897,"similar":[{"pmid":32397007,"title":"There is a relationship between obesity and COVID-19 but more information is needed.","text":["There is a relationship between obesity and COVID-19 but more information is needed.","We read with particular interest your comments in Obesity regarding the Coronavirus-19 (COVID-19) epidemic (1) and a related manuscript by Simonnet et al. (2). Resolution of the specific relationship between obesity and COVID-19, two existing public health epidemics, is critically needed to potentially prevent health systems worldwide from being overburdened. Few studies describing COVID-19 with rates of obesity exist, and most are based on heterogeneous populations (Table 1) (2-7). In cohort studies with COVID-19 disease, obesity rates are generally reported as no higher than population-based estimates; in contrast, subgroups of critically ill patients (e.g, intensive care unit (ICU)) report higher prevalence rates of obesity.","Obesity (Silver Spring)","Buscemi, Silvio","Buscemi, Carola","Batsis, John A","32397007"],"abstract":["We read with particular interest your comments in Obesity regarding the Coronavirus-19 (COVID-19) epidemic (1) and a related manuscript by Simonnet et al. (2). Resolution of the specific relationship between obesity and COVID-19, two existing public health epidemics, is critically needed to potentially prevent health systems worldwide from being overburdened. Few studies describing COVID-19 with rates of obesity exist, and most are based on heterogeneous populations (Table 1) (2-7). In cohort studies with COVID-19 disease, obesity rates are generally reported as no higher than population-based estimates; in contrast, subgroups of critically ill patients (e.g, intensive care unit (ICU)) report higher prevalence rates of obesity."],"journal":"Obesity (Silver Spring)","authors":["Buscemi, Silvio","Buscemi, Carola","Batsis, John A"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32397007","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/oby.22883","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666627827884097538,"score":89.10937},{"pmid":32438328,"title":"Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.","text":["Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.","BACKGROUND AND AIMS: COVID-19 is an emerging pandemic due to droplet infection of 2019-novel coronavirus (2019-nCoV). Due to its rapid transmission and high case-fatality rate, recognition of its risk and prognostic factor is important. Obesity has been associated with impaired immune system, increasing the susceptibility for 2019-nCoV infection. We aimed to study the impact of obesity to the prognosis and disease severity of COVID-19. METHODS: A systematic search and handsearching was conducted in four databases: Cochrane, MEDLINE, EMBASE, and PubMed. The identified articles were screened using the chosen eligibility criteria. We obtained three retrospective cohort studies (Wu J et al., Lighter J et al., and Simonnet A et al.) to be critically appraised using Newcastle Ottawa Scale. RESULTS: The findings of all included studies were consistent in stating the contribution of obesity as a risk factor to increase the requirement for advanced medical care. Study with the highest quality, Simonnet A et al., reported an increase need of invasive mechanical ventilation in COVID-19 patients with body mass index higher than 35 kg/m(2), OR: 7.36 (1.63-33.14; p = 0.021). This is associated with a higher mortality rate in obese population infected with COVID-19. CONCLUSION: Obesity is an independent risk and prognostic factor for the disease severity and the requirement of advanced medical care in COVID-19. This systematic review highlights a particularly vulnerable group - obese, and emphasises on the importance of treatment aggression and disease prevention in this population group.","Diabetes Metab Syndr","Tamara, Alice","Tahapary, Dicky L","32438328"],"abstract":["BACKGROUND AND AIMS: COVID-19 is an emerging pandemic due to droplet infection of 2019-novel coronavirus (2019-nCoV). Due to its rapid transmission and high case-fatality rate, recognition of its risk and prognostic factor is important. Obesity has been associated with impaired immune system, increasing the susceptibility for 2019-nCoV infection. We aimed to study the impact of obesity to the prognosis and disease severity of COVID-19. METHODS: A systematic search and handsearching was conducted in four databases: Cochrane, MEDLINE, EMBASE, and PubMed. The identified articles were screened using the chosen eligibility criteria. We obtained three retrospective cohort studies (Wu J et al., Lighter J et al., and Simonnet A et al.) to be critically appraised using Newcastle Ottawa Scale. RESULTS: The findings of all included studies were consistent in stating the contribution of obesity as a risk factor to increase the requirement for advanced medical care. Study with the highest quality, Simonnet A et al., reported an increase need of invasive mechanical ventilation in COVID-19 patients with body mass index higher than 35 kg/m(2), OR: 7.36 (1.63-33.14; p = 0.021). This is associated with a higher mortality rate in obese population infected with COVID-19. CONCLUSION: Obesity is an independent risk and prognostic factor for the disease severity and the requirement of advanced medical care in COVID-19. This systematic review highlights a particularly vulnerable group - obese, and emphasises on the importance of treatment aggression and disease prevention in this population group."],"journal":"Diabetes Metab Syndr","authors":["Tamara, Alice","Tahapary, Dicky L"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438328","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.dsx.2020.05.020","keywords":["covid-19","obesity","predictor","prognosis"],"locations":["obese"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667521393560911872,"score":81.08757},{"pmid":32409502,"title":"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.","text":["Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.","OBJECTIVE: Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS: A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m(2), normal weight as 18.5-23.9 kg/m(2), overweight as 24.0-27.9 kg/m(2), and obesity as >/=28 kg/m(2). RESULTS: Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003). CONCLUSIONS: In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment.","Diabetes Care","Cai, Qingxian","Chen, Fengjuan","Wang, Tao","Luo, Fang","Liu, Xiaohui","Wu, Qikai","He, Qing","Wang, Zhaoqin","Liu, Yingxia","Liu, Lei","Chen, Jun","Xu, Lin","32409502"],"abstract":["OBJECTIVE: Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS: A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m(2), normal weight as 18.5-23.9 kg/m(2), overweight as 24.0-27.9 kg/m(2), and obesity as >/=28 kg/m(2). RESULTS: Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003). CONCLUSIONS: In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment."],"journal":"Diabetes Care","authors":["Cai, Qingxian","Chen, Fengjuan","Wang, Tao","Luo, Fang","Liu, Xiaohui","Wu, Qikai","He, Qing","Wang, Zhaoqin","Liu, Yingxia","Liu, Lei","Chen, Jun","Xu, Lin"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409502","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.2337/dc20-0576","locations":["Shenzhen","China","Obese","obese","obese","obese","obese","obese","Shenzhen","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666897319116668929,"score":78.96664},{"pmid":32352637,"title":"Association of Obesity with Disease Severity among Patients with COVID-19.","text":["Association of Obesity with Disease Severity among Patients with COVID-19.","OBJECTIVE: To explore the potential association of obesity and other chronic diseases with severe outcomes, such as intensive care unit (ICU) admission and invasive mechanical ventilation (IMV), in patients hospitalized with COVID-19. METHODS: Retrospective cohort of 103 patients hospitalized with COVID-19. Demographic data, past medical history and hospital course were collected and analyzed. A multivariate logistic regression analysis was implemented to examine associations. RESULTS: From February 17th to April 5th, 103 consecutive patients were hospitalized with COVID-19. Among them, 41 patients (39.8%) were admitted to the ICU and 29 (70.7%) required (IMV). The prevalence of obesity was 47.5% (49/103). In a multivariate analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13-25.64). Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05-11.06), obesity (BMI=30-34.9 kg/m2) (aOR 6.85; 95% CI: 1.05-44.82) or severe obesity (BMI>/=35 kg/m2) (aOR 9.99; 95% CI:1.39-71.69). CONCLUSION: In our analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI >/=30 kg/m2) were independently associated with the use of IMV. Increased vigilance and aggressive treatment of patients with obesity and COVID-19 are warranted.","Obesity (Silver Spring)","Kalligeros, Markos","Shehadeh, Fadi","Mylona, Evangelia K","Benitez, Gregorio","Beckwith, Curt G","Chan, Philip A","Mylonakis, Eleftherios","32352637"],"abstract":["OBJECTIVE: To explore the potential association of obesity and other chronic diseases with severe outcomes, such as intensive care unit (ICU) admission and invasive mechanical ventilation (IMV), in patients hospitalized with COVID-19. METHODS: Retrospective cohort of 103 patients hospitalized with COVID-19. Demographic data, past medical history and hospital course were collected and analyzed. A multivariate logistic regression analysis was implemented to examine associations. RESULTS: From February 17th to April 5th, 103 consecutive patients were hospitalized with COVID-19. Among them, 41 patients (39.8%) were admitted to the ICU and 29 (70.7%) required (IMV). The prevalence of obesity was 47.5% (49/103). In a multivariate analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13-25.64). Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05-11.06), obesity (BMI=30-34.9 kg/m2) (aOR 6.85; 95% CI: 1.05-44.82) or severe obesity (BMI>/=35 kg/m2) (aOR 9.99; 95% CI:1.39-71.69). CONCLUSION: In our analysis, severe obesity (BMI >/=35 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI >/=30 kg/m2) were independently associated with the use of IMV. Increased vigilance and aggressive treatment of patients with obesity and COVID-19 are warranted."],"journal":"Obesity (Silver Spring)","authors":["Kalligeros, Markos","Shehadeh, Fadi","Mylona, Evangelia K","Benitez, Gregorio","Beckwith, Curt G","Chan, Philip A","Mylonakis, Eleftherios"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352637","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/oby.22859","keywords":["covid-19","icu","sars-cov-2","hospitalization","intubation","obesity"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495752601600,"score":78.70431},{"pmid":32384227,"title":"COVID-19 ventilatory phenotypes and obesity: is there a relationship?","text":["COVID-19 ventilatory phenotypes and obesity: is there a relationship?","Obesity has been recognized as an independent risk factor in other viral infections such as H1N1 (1). Although data are scarce at this stage, there is also an unexplained increased prevalence of obesity in patients infected with SARS-CoV-2 admitted to the intensive care units (ICU) (2).","Obesity (Silver Spring)","Costa, Hugo","Jacob, Miguel","Pereira, Rafaela","Calcas, Roberto","32384227"],"abstract":["Obesity has been recognized as an independent risk factor in other viral infections such as H1N1 (1). Although data are scarce at this stage, there is also an unexplained increased prevalence of obesity in patients infected with SARS-CoV-2 admitted to the intensive care units (ICU) (2)."],"journal":"Obesity (Silver Spring)","authors":["Costa, Hugo","Jacob, Miguel","Pereira, Rafaela","Calcas, Roberto"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32384227","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/oby.22877","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666419683241230336,"score":78.39027}]}